144 related articles for article (PubMed ID: 11313931)
1. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
Kasten M; Giordano A
Oncogene; 2001 Apr; 20(15):1832-8. PubMed ID: 11313931
[TBL] [Abstract][Full Text] [Related]
2. Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle.
Bagella L; Giacinti C; Simone C; Giordano A
J Cell Biochem; 2006 Oct; 99(3):978-85. PubMed ID: 16741970
[TBL] [Abstract][Full Text] [Related]
3. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
4. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
5. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
Ohtani N; Zebedee Z; Huot TJ; Stinson JA; Sugimoto M; Ohashi Y; Sharrocks AD; Peters G; Hara E
Nature; 2001 Feb; 409(6823):1067-70. PubMed ID: 11234019
[TBL] [Abstract][Full Text] [Related]
8. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
Wasylyk C; Bradford AP; Gutierrez-Hartmann A; Wasylyk B
Oncogene; 1997 Feb; 14(8):899-913. PubMed ID: 9050989
[TBL] [Abstract][Full Text] [Related]
9. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A.
Wen SC; Ku DH; De Luca A; Claudio PP; Giordano A; Calabretta B
Exp Cell Res; 1995 Mar; 217(1):8-14. PubMed ID: 7867724
[TBL] [Abstract][Full Text] [Related]
10. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
11. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
12. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
[TBL] [Abstract][Full Text] [Related]
14. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
15. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
Butticè G; Duterque-Coquillaud M; Basuyaux JP; Carrère S; Kurkinen M; Stéhelin D
Oncogene; 1996 Dec; 13(11):2297-306. PubMed ID: 8957070
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
17. Mouse models in the study of the Ets family of transcription factors.
Bartel FO; Higuchi T; Spyropoulos DD
Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
[TBL] [Abstract][Full Text] [Related]
18. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
Guen VJ; Gamble C; Flajolet M; Unger S; Thollet A; Ferandin Y; Superti-Furga A; Cohen PA; Meijer L; Colas P
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19525-30. PubMed ID: 24218572
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
Foos G; García-Ramírez JJ; Galang CK; Hauser CA
J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
[TBL] [Abstract][Full Text] [Related]
20. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]